Recent events
Recent events tied to this brand in public sources.
Back to profile10 entries
2022
TriRx completes acquisition of Elanco's Speke manufacturing facility
TriRx completed its acquisition of ownership and operations of Elanco's manufacturing site in Speke, United Kingdom; TriRx officially took ownership on February 1, 2022.
2021
TriRx and Elanco enter long-term supply agreement
TriRx and Elanco entered into a long-term supply agreement for the Shawnee site to ensure continued supply of Elanco products.
2021
TriRx completes acquisition of Elanco's Shawnee facility
TriRx completed its acquisition of ownership and operations of Elanco's Shawnee, Kansas manufacturing site. The sale included the site's physical assets and employment of approximately 300 personnel.
2020
MSD completes acquisition of Vecoxan worldwide rights
MSD Animal Health completed its $55 million acquisition from Elanco Animal Health of the worldwide rights to Vecoxan, an oral suspension used to prevent and treat coccidiosis in calves and lambs.
2020
Elanco completes acquisition of Bayer Animal Health
Elanco completed its acquisition of Bayer Animal Health on Monday. The deal was valued at $6.9 billion.
2020
Dechra completes acquisition of worldwide Osurnia rights
Dechra Pharmaceuticals completed its acquisition of the worldwide rights to the Osurnia product portfolio from Elanco Animal Health for USD 135.0 million (£104.7 million).
2020
Neogen plans to acquire U.S. rights to Elanco's StandGuard Pour-on
Neogen plans to acquire the U.S. rights to Elanco's StandGuard Pour-on and related assets. The transaction had not yet closed; the article said closing remained subject to a final Federal Trade Commission consent relating to Elanco's acquisition of Bayer's global animal health business.
2020
VetNOW partners with Elanco to provide veterinary telehealth access
VetNOW partnered with Elanco Animal Health to provide veterinarians access to VetNOW's telehealth platform, including specialist consultations; the article says about 12,000 veterinarians are expected to be onboarded in the coming months.
2020
Dechra agrees to acquire worldwide rights to Osurnia
Dechra announced that it had agreed terms to acquire the worldwide rights to Elanco's Osurnia product portfolio for USD 135.0 million. Completion was expected before the end of June 2020, subject to conditions and regulatory approvals.
2019
Elanco sells its Victoria aquaculture R&D facility to CATC
Elanco sold its aquaculture research and development facility in Victoria, Prince Edward Island, to the Center for Aquaculture Technologies Canada (CATC). The article says the transaction was expected to close in early 2020, so it reports a sale agreement rather than a completed closing.